Filing Details

Accession Number:
0001181431-12-064662
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-14 08:11:01
Reporting Period:
2012-12-12
Filing Date:
2012-12-14
Accepted Time:
2012-12-14 08:11:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325879 Aveo Pharmaceuticals Inc AVEO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1241221 Tuan Ngoc Ha C/O Aveo Pharmaceuticals, Inc.
75 Sidney Street
Cambridge MA 02139
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-09-14 33,793 $0.00 239,640 No 4 J Direct
Common Stock Disposition 2012-09-14 33,793 $0.00 118,187 No 4 J Indirect Held by GRAT
Common Stock Acquisiton 2012-12-12 60,900 $6.61 300,540 No 4 P Direct
Common Stock Acquisiton 2012-12-13 14,100 $6.85 314,640 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Direct
No 4 J Indirect Held by GRAT
No 4 P Direct
No 4 P Direct
Footnotes
  1. The increase of shares of directly held common stock was due to a distribution from the Tuan Ha-Ngoc 2009 GRAT to the reporting person on September 14, 2012.
  2. Includes 1208 shares acquired on June 30, 2012 under the AVEO Pharmaceuticals, Inc. Employee Stock Purchase Plan.
  3. The decrease of shares of indirectly held common stock was due to a distribution from the Tuan Ha-Ngoc 2009 GRAT to the reporting person on September 14, 2012.
  4. Shares are held by Gabriel Schmergel, Trustee, or his successor in trust, of the Tuan Ha-Ngoc 2009 GRAT. Mr. Schmergel is trustee of the Tuan Ha-Ngoc 2009 GRAT and he exercises sole voting and investment power over the shares held of record by such trust. Mr. Ha-Ngoc disclaims beneficial ownership over all such shares, except to the extent of his pecurniary interest therein.